Trial Profile
Corticosteroids as Co-Induction Agents With Vedolizumab in Crohn's Disease: a Double-blind Placebo Controlled Randomized Trial
Status:
Discontinued
Phase of Trial:
Phase IV
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Prednisone (Primary) ; Vedolizumab (Primary)
- Indications Crohn's disease
- Focus Therapeutic Use
- 20 Aug 2018 Status changed from recruiting to discontinued due to difficulty in recruitment
- 13 Jun 2017 Planned End Date changed from 1 Mar 2017 to 1 Jun 2018.
- 13 Jun 2017 Planned primary completion date changed from 1 Jan 2017 to 1 Jun 2018.